Big Cypress Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BCYP and buy or sell other stocks, ETFs, and their options commission-free!About BCYP
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
CEOSamuel J. Reich
CEOSamuel J. Reich
Employees63
Employees63
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2014
Founded2014
Employees63
Employees63
BCYP Key Statistics
Market cap55.38M
Market cap55.38M
Price-Earnings ratio-0.78
Price-Earnings ratio-0.78
Dividend yield—
Dividend yield—
Average volume198.48K
Average volume198.48K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.60
52 Week high$6.60
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
As of today, Big Cypress Acquisition(BCYP) shares are valued at $5.96. The company's market cap stands at 55.38M, with a P/E ratio of -0.78.
On 2025-11-07, Big Cypress Acquisition(BCYP) stock opened at —, reached a high of —, and a low of —.
Big Cypress Acquisition(BCYP) shares are trading with a volume of 0, against a daily average of 198.48K.
In the last year, Big Cypress Acquisition(BCYP) shares hit a 52-week high of $6.60 and a 52-week low of $1.00.
In the last year, Big Cypress Acquisition(BCYP) shares hit a 52-week high of $6.60 and a 52-week low of $1.00.
People also own
Based on the portfolios of people who own BCYP. This list is generated using Robinhood data, and it’s not a recommendation.